
Sierra Oncology (SRRA) Earnings Dates & Reports
Sierra Oncology (SRRA) Most Recent Earnings
Report DateMay 6, 2022
Period EndingQ1 2022
Est. EPS-$1.03
Actual EPS-$1.33
EarningsMiss
Sierra Oncology (SRRA) Earnings
View the latest Sierra Oncology (SRRA) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Sierra Oncology (SRRA)
Order type
Buy in
Order amount
Est. shares
0 shares
Sierra Oncology (SRRA) Earnings per Share (EPS) History
Signup for full accessBrowse free
Sierra Oncology (SRRA) Latest Earnings
The value each SRRA share was expected to gain vs. the value each share gained.
Sierra Oncology (SRRA) reported its most recent earnings on May 6, 2022 for Q1 2022, posting earnings per share (EPS) of -$1.33. This exceeded analysts' expectations of -$1.03 by 29.13%, marking a Miss.
For comparison, Sierra Oncology reported EPS of -$1.46 in the same quarter last year.
The company is expected to announce its next earnings report on 05/06/2022, with analysts projecting an EPS of $0.
Sierra Oncology (SRRA) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q1 2022May 6, 2022 | -$1.03 | -$1.33 | +29.13% | |
Q4 2021Mar 10, 2022 | -$1.54 | -$1.44 | -6.49% | |
Q3 2021Nov 5, 2021 | -$1.51 | -$1.86 | +23.18% | |
Q2 2021Aug 5, 2021 | -$1.61 | -$1.41 | -12.42% | |
Q1 2021May 7, 2021 | -$1.45 | -$1.46 | +0.69% | |
Sierra Oncology (SRRA) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Sierra Oncology’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Mar 10, 2022 | — | — | — |
Nov 5, 2021 | — | — | — |
Aug 5, 2021 | — | — | — |
May 7, 2021 | — | — | — |
Sierra Oncology (SRRA) Earnings FAQs
Sierra Oncology (SRRA) last reported earnings on May 6, 2022 for Q1 2022, posting an EPS of -$1.33, which Miss the estimate of -$1.03 by 29.13%.
For Q1 2022, Sierra Oncology (SRRA) reported an EPS of -$1.33, missing analysts' estimate of -$1.03 by 29.13%.
For Q1 2022, Sierra Oncology (SRRA) Miss expectations with an actual EPS of -$1.33 vs. an estimated EPS of -$1.03.
Following the last earnings report on May 6, 2022, Sierra Oncology (SRRA)'s stock price moved — from — to —.
The next Sierra Oncology (SRRA) earnings call is scheduled for May. 6, 2022, where executives will discuss financial results and outlook.